OraSure Technologies: Kenneth McGrath, Scott Gleason, Mara Aspinall
OraSure Technologies has appointed Kenneth McGrath as CFO, replacing Scott Gleason, who had served as interim CFO and will continue leading investor relations and corporate communications. McGrath was most recently with Quest Diagnostics as its VP of finance. Prior to that, he held various leadership positions in finance with Johnson & Johnson.
OraSure also announced that Michael Celano, chairman of the board, and Ronny Lancaster and Eamonn Hobbs have resigned from the board, reducing its size to seven from 10. Effective Nov. 8, Mara Aspinall will become chairman of OraSure's board. She is managing director of Health Catalysts Group and BlueStone Venture Partners. She previously was chief executive of Ventana Medical Systems, now Roche Tissue Diagnostics. She was also chief executive of Genzyme Genetics. Additionally, Aspinall cofounded the Biomedical Diagnostics Master Degree program at Arizona State University.